Lab Automation Companies | Forecast by 2033


09 Aug 2024

Share : linkedin twitter facebook

The global lab automation market was exhibited at USD 7.35 billion in 2023 and is predicted to attain around USD 13.95 billion by 2033, poised to grow at a CAGR of 6.55% during the forecast period. Rising technological advancements in artificial intelligence and robotics are expected to drive market growth.

Lab Automation Market Statistics

 

The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/3376

Market Overview

The lab automation market refers to the use of any device or equipment that may streamline tasks in the lab with no hands-on or little engagement from professionals. Lab automation uses a special technology to substitute or streamline the manual manipulation of equipment and methods. The degree and level of automation are decided based on the laboratory workflow.

The continuous adoption of automated instruments is mostly observed at research and academic institutes to improve productivity, reduce the time spent on various time-consuming tasks, and further propel the growth of the lab automation market during the forecast period.

The increasing demand for high-throughput analysis to streamline huge numbers of samples and the growing demands for productivity and efficiency in research and development across industries such as healthcare, biotechnology, and pharmaceuticals are further expected to drive market growth in the estimated period.

  • The increasing demands for technological advancements, data management, and efficiency contributed to propel the growth of the lab automation industry.
  • The growing use of automated instruments in drug development and discovery is expected to drive market growth.
  • The increasing interoperability and connectivity of systems and devices are anticipated to enhance the growth of the lab automation market during the forecast period.

Increase biotech and pharmaceutical R&D expenditures to enhance market growth

Investments and funding are crucial for lab automation in improving patient outcomes, advancing research and development, and driving innovation. Investments come from many sources, such as venture capitalists, associations, and governments. Various programs are provided to students, scientists, entrepreneurs, start-ups, pharmaceuticals, and biopharmaceuticals in multiple regions of the globe.

This program awards consultations, services, and products to the awardees to aid in enhancing their growth in the market. In addition, increasing investments and funding are enhancing the growth of the life science sector and improving the adoption of laboratory automation equipment. Thus, these driving factors are anticipated to enhance the growth of the lab automation market during the forecast period.

However, the slow adoption of automation by laboratories and diagnostics may restrain the market growth. Budget concerns can be a major challenge for medium-sized and small-sized laboratories. The service costs and high maintenance related to laboratory informatics solutions may restrain market growth. Lack of evidence on the cost-effectiveness, low risk-taking capabilities, and budget constraints of automation solutions for medium and small-sized labs may create obstacles. Thus, these factors are expected to restrain the growth of the lab automation market.

Lab Automation Market Top Companies

  • QIAGEN
  • Abbott
  • Carbon
  • PerkinElmer Inc.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Agilent Technologies, Inc.
  • Eppendorf SE
  • Hudson Robotics
  • Aurora Biomed Inc.
  • BMG LABTECH GmbH
  • Tecan Trading AG
  • Hamilton Company
  • F. Hoffmann-La Roche Ltd.

Recent Innovation in the Lab Automation Market by Carbon

  • In February 2024, a leading product manufacturing and development technology company, Carbon, launched its Automation Operation suite of solutions. The aim behind this launch was to transform the landscape of dental laboratory automation. In addition, the innovation suite of automation was designed to set a new standard in lab automation and automation.

Recent Innovation in the Lab Automation Market by Abbott

  • In March 2024, Abbott announced the launch of GLP Systems Track, an innovative automation solution to support the high-volume needs of laboratories. These new automation solutions offered efficiency to address growing demand, helping laboratories optimize performance and more flexibility. This GLP systems Track can help increase the quality and accessibility of care by automating lab operations.

Regional Insights

Asia Pacific is expected to grow fastest during the forecast period

The lab automation market is driven by various factors such as increasing supportive government policies to improve lab automation, increasing investments by market players to launch novel systems in the region, and a growing number of middle and small-sized laboratories in the region. China, India, Japan, and South Korea are the major countries in the region. China and India are providing funding and implementing initiatives to improve the adoption of lab automation technologies. These countries are the major contributors to the market growth, and they are further expected to drive the growth of the lab automation market in Asia Pacific.

  • For instance, in December 2023, XtalPi and ABB Robotics entered a strategic partnership to produce a range of automated laboratory workstations. Automated and new laboratories boosted the productivity of research and development processes in new energy materials, chemistry, chemical engineering, and biopharmaceuticals.

North America dominated the lab automation market in 2023

The market is enhanced by the dynamic sector in the life sciences and laboratory technology landscape in the region. The region significantly depends on lab automation solutions to enhance efficiency, accuracy, and productivity due to the well-established infrastructure, such as clinical laboratories, biotechnology firms, pharmaceutical companies, healthcare facilities, and research institutions. The U.S. and Canada are the major countries in the region. The rising necessity for dependable and speedy diagnostic testing, the increasing demand for personalized medicine, and the continuous focus on drug development and discovery are further expected to drive the growth of the lab automation market in North America.

  • For instance, in March 2024, US-based Cognition launched the world’s first AI software engineer for lab automation. This innovation helped fuel debates about the trajectory of automation and its impact on development. Cognition is a US-based applied AI lab focused on reasoning.
  • In June 2023, Thermo Scientific Heracell VIOS 250i AxD CO2 Incubators were launched by Thermo Fisher Scientific in the US to support future implementation. This launch aimed to support the future implementation of workflow automation in cell therapy production. These CO2 incubators are designed for development in molecular and automated laboratories.

Market Potential and Growth Opportunity

Increasing adoption of laboratory automation for genomics and personalized medicine

The increasing adoption and awareness of personalized medicines are considered to create growth opportunities for the market players operating in the market for lab automation. The increasing adoption and awareness of personalized medicines enhance the demand for automated and specialized lab technologies and equipment that allow accurate, error-free, and precise molecular and genetic analysis.

Personalized medicine significantly depends on biomarker validation and identification, proteomic & genomic information analysis, sequencing, and genetic testing necessitating the use of advanced lab equipment, such as chromatography systems, immunoassay analyzers, mass spectrometers, next-generation sequencers, real-time PCR systems, PCR machines, gene sequencers, and DNA sequencers to manufacture accurate results. In addition, there has been significant demand for DNA sequencing in personalized medicine, clinical diagnostics, and genomics research, with advancements in DNA sequencing technologies. These factors are expected to boost the growth of the lab automation market in the coming years.

Lab Automation Market Highlights

Report Attribute Key Statistics
Market Revenue in 2024 USD 7.84 Billion
Market Revenue by 2033 USD 13.95 Billion
CAGR 6.55%
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2023
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Lab Automation Market News

  • In April 2024, India’s first-ever total Lab Automation in Diagnostic Laboratory Services was launched by Ruby Hall Clinic. It was an advanced solution by Beckman Coulter USA. In these advanced automation laboratories, thousands of samples of patients are processed manually. Ruby Hall Clinic met challenges by reducing costs, improving efficiency, reducing significant errors, and introducing Total Lab Automation.
  • In May 2024, Olden Labs launched its world’s first automated animal research lab by harnessing robotics, genetic engineering, and artificial intelligence. Olden Labs has developed three first-in-class technologies in gene delivery, AI, and robotics to enable automated animal studies.

Market Segmentation

By Process

  • Discrete Processing
  • Continuous Flow

By Automation Type

  • OEM
  • Aftermarket

By End-User

  • Modular Automation Systems
  • Total Automation Systems

Buy this Research Report@ https://www.precedenceresearch.com/checkout/3376

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308

Related Reports